Welcome to our dedicated page for Smartkem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating the real story inside SmartKem’s dense SEC paperwork can be daunting. Each 10-Q details R&D burn rates, pilot-line yields in Sedgefield, and new TRUFLEX ink qualifications; Form 4s flag when executives buy shares, hinting at confidence in flexible display adoption. If you have ever searched for “SmartKem insider trading Form 4 transactions” or wondered how a micro-cap materials innovator funds next-gen OTFTs, you know the challenge.
Stock Titan solves this problem with AI-powered analysis tuned for semiconductor disclosures. Our engine converts every SmartKem quarterly earnings report 10-Q filing, annual report 10-K, and 8-K material events into concise language, so you can grasp cash runway or new AMOLED partner announcements in minutes. Interactive tools surface:
- Real-time SmartKem Form 4 insider transactions alerts
- Side-by-side trend charts of R&D versus revenue growth
- Plain-English answers to common queries like “understanding SmartKem SEC documents with AI”
Whether you need “SmartKem proxy statement executive compensation” details before the AGM or a quick take on “SmartKem annual report 10-K simplified”, you’ll find every filing type—10-K, 10-Q, 8-K, S-1, SC 13G—updated the moment EDGAR publishes. Our summaries spotlight:
- Progress of TRUFLEX ink commercialization with ITRI and RiTdisplay
- Patent portfolio additions that protect organic transistor chemistry
- Liquidity metrics crucial to ongoing pilot production
Stop combing through 200-page PDFs. Explore “SmartKem earnings report filing analysis” or “SmartKem 8-K material events explained” in seconds, gain clarity on executive stock moves, and make informed decisions faster.
SmartKem, Inc. (SMTK) director Joseph Christopher Lizzio reported a sale of 150,000 shares on 09/10/2025 coded as a G transaction (price reported as $0), leaving him with 419,000 shares beneficially owned. The Form 4 was signed 09/25/2025 and indicates the filing is by one reporting person. No derivative transactions or additional details are disclosed in this filing.
SmartKem, Inc. (SMTK) director Joseph Christopher Lizzio filed an Initial Statement of Beneficial Ownership reporting direct ownership of 569,000 shares of common stock. The event requiring the statement is dated 09/08/2025, and the form is signed on 09/25/2025. The filing is a Form 3 (initial disclosure) indicating the reporting person is a director and the form was filed by one reporting person.
Joseph Christopher Lizzio reported beneficial ownership of 419,000 shares of SmartKem, Inc. common stock, representing 7.65% of the outstanding shares as of September 4, 2025. This total includes 180,000 shares held jointly with his spouse; the filing states he does not exercise voting or dispositive power over shares held by his adult children. The percentages are calculated using 5,479,787 shares outstanding based on the issuers SEC filing dated September 5, 2025. The Schedule 13G indicates the holdings were not acquired to influence control of the issuer, and the filing is signed and certified by Mr. Lizzio on September 24, 2025.
Insider option grant reported for SmartKem, Inc. (SMTK). Director Melisa Denis was granted a stock option to buy 22,466 shares of common stock at an exercise price of $1.16 per share, with a transaction date of 09/03/2025 and an expiration date of 09/03/2035. The option vests 25% on the grant date and the remaining shares vest in equal monthly installments over 36 months beginning 09/03/2025. The reporting was filed on 09/05/2025 and signed by an attorney-in-fact.
SmartKem, Inc. director Klaas de Boer was granted a stock option on 09/03/2025 for 22,466 shares with an exercise price of $1.16. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months commencing on 09/03/2025. The option appears to expire on 09/03/2035. The Form 4 was filed by an attorney-in-fact, Ian Jenks, on 09/05/2025. The reporting person is identified as a director and the filing is made by one reporting person.
SmartKem, Inc. (SMTK) Form 4 shows Ian Jenks, Chairman & CEO and Director, was granted a stock option on 09/03/2025 to acquire 160,005 shares of Common Stock at an exercise price of $1.16 per share. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option is exercisable through 09/03/2035. The Form 4 was signed by Ian Jenks on 09/05/2025.
Insider grant and holdings summary: SmartKem CFO Barbra Keck was granted a stock option on 09/03/2025 giving the right to buy 71,077 shares of common stock at an exercise price of $1.16 per share. The option is exercisable through 09/03/2035. Following the grant, Keck beneficially owns 71,077 underlying shares, held directly. The option vests 25% at grant with the remainder vesting in equal monthly installments over 36 months beginning 09/03/2025, with monthly vesting on the 3rd.
Peruvemba Sriram Krishnamurthy, a director of SmartKem, Inc. (SMTK), was granted a stock option on 09/03/2025 for the right to buy 22,466 shares of Common Stock at an exercise price of $1.16 per share. The option was acquired and is exercisable under a schedule that vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option expires on September 3, 2035. Following the reported transaction the reporting person directly beneficially owns 22,466 option shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/05/2025.
FAQ
What is the current stock price of Smartkem (SMTK)?
What is the market cap of Smartkem (SMTK)?
